| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |